A nationwide recall on thyroid tablets has now been classified as one the U.S. Food and Drug Administration's most serious and urgent recalls. According to the recall alert, which was first announced in August, there were concerns that the medication could be overly potent and potentially cause symptoms related to an overactive thyroid. See the link in bio for details. #FDA #RecallNotice #VitruviasTherapeutics #ThyroidTablets #PublicHealthSafety #Hyperthyroidism #MedicationAlert